# Acurx Pharmaceuticals, Inc.: Form S-1, filed Jun 29, 2023

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: S-1
- Filed: 2023-06-29
- Accepted by EDGAR: Jun 29, 2023, 16:07 ET
- Period: not reported
- Accession: 0001104659-23-076317
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465923076317/tm2319782d1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465923076317/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465923076317/tm2319782d1_s1.htm

Filed Jun 29, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-076317. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
